Zoetis (ZTS) Tax Provisions (2012 - 2026)
Zoetis' (ZTS) quarterly Tax Provisions came in at $157.0 million in Q1 2026, down 8.19% year-on-year from $171.0 million in Q1 2025, and down 0.63% on a QoQ basis from $158.0 million in Q4 2025.
Zoetis (ZTS) Tax Provisions (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Tax Provisions data on file, last reported at $157.0 million in Q1 2026.
- On a quarterly basis, Tax Provisions fell 8.19% year-over-year to $157.0 million in Q1 2026; TTM through Mar 2026 was $665.0 million, a 0.76% increase from a year earlier, with the FY2025 full-year figure at $687.0 million, up 7.85% from the prior year.
- Tax Provisions for Q1 2026 stood at $157.0 million, down from $158.0 million in the prior quarter.
- Over the last five years, Tax Provisions for ZTS reached as high as $202.0 million in Q2 2023 and fell as low as $121.0 million in Q3 2023.
- Historically, Tax Provisions has averaged $153.8 million across 5 years, with a median of $151.0 million in 2024.
- On a YoY basis, Tax Provisions climbed as much as 50.41% in 2024 and fell as far as 22.77% in 2024.
- Year by year, Tax Provisions stood at $132.0 million in 2022, then dropped by 3.79% to $127.0 million in 2023, then grew by 18.9% to $151.0 million in 2024, then climbed by 4.64% to $158.0 million in 2025, then slipped by 0.63% to $157.0 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $157.0 million in Q1 2026, $158.0 million in Q4 2025, and $166.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 18.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.00 Mn |
| Dec 31, 2025 | 158.00 Mn |
| Sep 30, 2025 | 166.00 Mn |
| Jun 30, 2025 | 184.00 Mn |
| Mar 31, 2025 | 171.00 Mn |
| Dec 31, 2024 | 151.00 Mn |
| Sep 30, 2024 | 182.00 Mn |
| Jun 30, 2024 | 156.00 Mn |
| Mar 31, 2024 | 148.00 Mn |
| Dec 31, 2023 | 127.00 Mn |
| Sep 30, 2023 | 121.00 Mn |
| Jun 30, 2023 | 202.00 Mn |
| Mar 31, 2023 | 146.00 Mn |
| Dec 31, 2022 | 132.00 Mn |
| Sep 30, 2022 | 139.00 Mn |
| Jun 30, 2022 | 141.00 Mn |
| Mar 31, 2022 | 133.00 Mn |
| Dec 31, 2021 | 93.00 Mn |
| Sep 30, 2021 | 107.00 Mn |
| Jun 30, 2021 | 125.00 Mn |